Navigation Links
NUS researchers developed world's first fluorescent sensor to detect date rape drug
Date:3/28/2014

A team of researchers from the National University of Singapore (NUS) has developed the world's first fluorescent sensor to identify the presence of a drug known as GHB that is commonly used to spike beverages. When the sensor is mixed with a sample of a beverage containing GHB, the mixture changes colour in less than 30 seconds, making detection of the drug fast and easy.

This simple mix-and-see discovery, led by Professor Chang Young-Tae of the Department of Chemistry at the NUS Faculty of Science, is a novel scientific breakthrough that contributes towards prevention of drug-facilitated sexual assault problems.

The findings were first published in the journal Chemical Communications earlier this year.

GHB: notorious drug used in drink spiking

Gamma-hydroxybutyric acid, commonly known as GHB, is a central nervous system depressant that has been used in the medical setting as a general anaesthetic. In the 1990s, it gained notoriety as a drug allegedly used in instances of drink spiking. Today, it is one of the most commonly used date rape drugs, rendering the victim incapacitated and vulnerable to sexual assault.

As GHB is odourless, colourless and slightly salty, it is almost undetectable when mixed in a drink, thus making it desirable to sexual predators. A small amount of between two to four grams of GHB will interfere with the motor and speech control of a person, and may even induce a coma-like sleep. GHB takes effect within 15 to 30 minutes, and the effect can last for three to six hours. It is only detectable in urine six to 12 hours after ingestion.

Novel fluorescent sensor to detect GHB

Fluorescent dyes have been widely used as sensors for analytical purposes because of their high sensitivity, fast response time and technical simplicity.

Under the supervision of Prof Chang, the team of researchers, comprising Dr Zhai Duanting, a Research Fellow, Mr Xu Wang, a PhD candidate, as well as Mr Elton Tan, a recent graduate, of the Department of Chemistry at the NUS Faculty of Science, screened 5,500 dyes generated from different fluorescent scaffolds. These fluorescent scaffolds have been used to construct the Diversity Oriented Fluorescence Library (DOFL) that was developed by Prof Chang over the last decade.

The team shortlisted 17 fluorescent compounds and further tested them with a wide range of different GHB concentrations. Through this, the team identified that an orange fluorescent compound, coined GHB Orange, changes colour when it is mixed with GHB.

In order to examine the efficiency of GHB Orange, the team tested its detection capability by mixing a small amount of it with samples of various beverages, ranging from alcoholic, non-alcoholic, coloured and colourless drinks, which contain GHB. The test revealed differences in the fluorescence intensity between GHB-free and GHB-spiked beverages. For drinks that are translucent or of a light colour, such as water or vodka, the change in colour can be easily detected with the naked eye. The change in the colour of darker drinks, such as Cola and whiskey, requires the aid of additional lighting to better detect the change.

Remarkably, this detection can be done through a simple mix-and-see process, which takes less than 30 seconds.

Future plans

While GHB Orange has proven to be efficient in detecting GHB in beverages, there is a need to develop a test kit that is convenient for users to use and carry around. Prof Chang and his team intend to work with industry partners to develop a handy and cheap device for GHB detection.


'/>"/>

Contact: Carolyn Fong
carolyn@nus.edu.sg
65-651-65399
National University of Singapore
Source:Eurekalert  

Related medicine news :

1. Cancer researchers find key protein link
2. Researchers: Biomarkers predict effectiveness of radiation treatments for cancer
3. Researchers issue state-of-the-state on genetic-based testing and treatment for breast cancer
4. Researchers identify impaired new learning in persons with Parkinsons disease
5. Researchers identify potential new therapeutic target for controlling high blood sugar
6. Ottawa researchers find new pathway connected to type 2 diabetes
7. Shoulder revision repair surgery not as successful 2 years later, say researchers
8. Researchers find significant increase in painkillers prescribed to US adults in the ER
9. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
10. Researchers destroy cancer with cryoablation & nanoparticle-encapsulated anticancer drug
11. NYU researchers find majority of Latinas are unaware of their risk of diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NUS researchers developed world's first fluorescent sensor to detect date rape drug
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Compensation Research Institute (WCRI) officially opened registration today for its 33rd Annual ... in Boston, MA . , The theme of the conference is “Persistent Challenges ...
(Date:12/8/2016)... ... 2016 , ... CURE Media Group, the nation’s leading digital and print media ... Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President Michael ... Media Group is honored to team up with Upstage Lung Cancer in order to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... version gives development continuity to its innovative Unified Instance Manager architecture, meeting ... In addition, this new version optimizes the unattended auto-dialing system without agents, ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
(Date:12/8/2016)... 8, 2016  The global biosurgery market is expected ... forecast period of 2016 to 2021. The market is ... USD 18.21 billion in 2016. The market is primarily ... sports related injuries and spinal problems, increasing clearance of ... effective blood loss management. In this report, ...
Breaking Medicine Technology: